Clinical trial

A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft…

NCT00002378 · Hoffmann-La Roche, Industry · Completed

Key facts

NCT number NCT00002378
Title A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients
Official title A Randomized Phase IIIB Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) TID Regimen in Combination With Two NRTIs Versus Saquinavir Soft Gel Capsule (SGC) BID Regimen in Combination With Two NRTIs Versus Saquinavir Soft Gel Capsule (SGC) BID Plus Nelfinavir BID Plus a NRTI in HIV-1…
Lead sponsor Hoffmann-La Roche, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions HIV Infections
Intervention type Drug
Interventions Ritonavir, Nelfinavir mesylate, Saquinavir, Delavirdine mesylate, Lamivudine, Stavudine, Zidovudine
Enrollment 825
First posted Aug 31, 2001
Last update posted Jun 24, 2005
Countries Germany, Italy, Puerto Rico, Spain, United Kingdom, United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies